Drosocin, pyrrhocoricin, and apidaecin, representing the short (18-20 amino
acid residues) proline-rich antibacterial peptide family, originally isola
ted from insects, were shown to act on a target bacterial protein in a ster
eospecific manner. Native pyrrhocoricin and one of its analogues designed f
or this purpose protect mice from bacterial challenge and, therefore, may r
epresent alternatives to existing antimicrobial drugs. Furthermore, this mo
de of action can be a basis for the design of a completely novel set of ant
ibacterial compounds, peptidic or peptidomimetic, if the interacting bacter
ial biopolymers are known. Recently, apidaecin was shown to enter Escherich
ia coli and subsequently kill bacteria through sequential interactions with
diverse target macromolecules. In this paper report, we used biotin- and f
luorescein-labeled pyrrhocoricin, drosocin, and apidaecin analogues to iden
tify biopolymers that bind to these peptides and are potentially involved i
n the above-mentioned multistep killing process. Through Use of a biotin-la
beled pyrrhocoricin analogue, we isolated two interacting proteins from E.
coli. According to mass spectrometry, Western blot, and fluorescence polari
zation, the short, proline-rich peptides bound to DnaK, the 70-kDa bacteria
l heat shock protein, both in solution and on the solid-phase. GroEL, the 6
0-kDa chaperonin, also bound in solution. Control experiments with an unrel
ated labeled peptide showed that while binding to DnaK was specific for the
antibacterial peptides, binding to GroEL was not specific for these insect
sequences. The killing of bacteria and DnaK binding are related events, as
an inactive pyrrhocoricin analogue made of all-D-amino acids failed to bin
d. The pharmaceutical potential of the insect antibacterial peptides is und
erscored by the fact that pyrrhocoricin did not bind to Hsp70, the human eq
uivalent of DnaK. Competition assay with unlabeled pyrrhocoricin indicated
differences in GroEL and DnaK binding and a probable two-site interaction w
ith DnaK. In addition, all three antibacterial peptides strongly interacted
with two bacterial lipopolysaccharide (LPS) preparations in solution, indi
cating that the initial step of the bacterial killing cascade proceeds thro
ugh LPS-mediated cell entry.